Home/Recalls/CANADA-63962
Health CanadaGeneral Alert

Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity

Published: April 21, 2022Recall ID: 63962Category: generalCountry: Canada

Reason for Recall / Hazard

Contamination

Product Description & Identification

Continue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition may pose a greater health risk.Contact your health care provider to discuss other treatment options. There is currently a reduced supply of combination quinapril hydrochloride and hydrochlorothiazide nationally; however, other drug products are available for treating high blood pressure.If you have questions about the recall, contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical enquiries, and at 1-800-387-4974 for general enquiries.Report any health product-related side effects or complaints to Health Canada.

Affected Products

Accupril (quinapril hydrochloride) and Accuretic (quinapril hydrochloride and hydrochlorothiazide)

Additional Source Details

FieldValue
N I D63962
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/pfizer-recalls-accupril-blood-pressure-tablets-due-nitrosamine-impurity
IssueContamination
TitlePfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
ProductAccupril (quinapril hydrochloride) and Accuretic (quinapril hydrochloride and hydrochlorothiazide)
Archived0
CategoryDrugs
Last updated2022-04-21
OrganizationCommunications and Public Affairs Branch
What you should doContinue taking your medication unless you have been advised to stop by your health care provider. Not treating your condition may pose a greater health risk.Contact your health care provider to discuss other treatment options. There is currently a reduced supply of combination quinapril hydrochloride and hydrochlorothiazide nationally; however, other drug products are available for treating high blood pressure.If you have questions about the recall, contact Pfizer Canada ULC at 1-800-463-6001 or www.pfizermedinfo.ca for medical enquiries, and at 1-800-387-4974 for general enquiries.Report any health product-related side effects or complaints to Health Canada.

Overview

  • Recalling FirmCommunications and Public Affairs Branch
Official Agency Alert